Cargando…
Patients’ and clinicians’ expectations on integrative medicine Services for Diabetes: a focus group study
BACKGROUND: Difference of perspective between patients and physicians over integrative medicine (IM) research and service provision remains unclear despite significant use worldwide. We observed an exceptionally low utilisation of IM and potential underreporting in diabetes. We aimed to explore the...
Autores principales: | Chan, Kam Wa, Lee, Pak Wing, Leung, Crystal Pui Sha, Chan, Gary Chi Wang, Yiu, Wai Han, Cheung, Hoi Man, Li, Bin, Lok, Sarah Wing Yan, Li, Hongyu, Xue, Rui, Chan, Loretta Yuk Yee, Leung, Joseph Chi Kam, Lam, Tai Pong, Lai, Kar Neng, Tang, Sydney Chi Wai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331247/ https://www.ncbi.nlm.nih.gov/pubmed/32615961 http://dx.doi.org/10.1186/s12906-020-02994-5 |
Ejemplares similares
-
PRAgmatic Clinical Trial Design of Integrative MediCinE (PRACTICE): A Focus Group Series and Systematic Review on Trials of Diabetes and Kidney Disease
por: Chan, Kam Wa, et al.
Publicado: (2021) -
Global REnal Involvement of CORonavirus Disease 2019 (RECORD): A Systematic Review and Meta-Analysis of Incidence, Risk Factors, and Clinical Outcomes
por: Chan, Kam Wa, et al.
Publicado: (2021) -
Potential Therapeutic Targets of Rehmannia Formulations on Diabetic Nephropathy: A Comparative Network Pharmacology Analysis
por: Chan, Kam Wa, et al.
Publicado: (2022) -
Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy
por: Yiu, Wai Han, et al.
Publicado: (2021) -
Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trial
por: Chan, Kam Wa, et al.
Publicado: (2016)